Berkeley Entrepreneurs Forum

Thursday, May 1, 2008

6:00 - 8:30 PM

Arthur Andersen Auditorium
Haas School of Business

To Register     Parking Information

The UC Berkeley Entrepreneurs Forum will present a very special program on May 1st when it joins with the student organizers of the 2008 UC Berkeley Business Plan Competition to showcase the finalists of this year's competition and award prizes. The San Francisco Bay Area entrepreneurial communtiy is invited to join US for a great evening learning about the best and the brightest from UC Berkeley. All those present will be invited to participate in the selection of the winner of the People's Choice Award, which carries a $5000 prize.

The Finalists:

 

Team	Business Description
Carsala	Carsala leverages its proprietary technology to make used car buying a hassle-free process and save car buyers thousands of dollars. Using its proprietary technology, Carsala acts as a buyer's agent, finding the right car and negotiating with dealers to obtain the lowest price possible. Carsala has proven its technology in the last six months, saving thousands of dollars for its customers: 25-30% below Kelley Blue Book on average.
Glycometrix	Glycometrix offers novel and proprietary glycan-based blood serum testing technologies that provide an efficient and economic solution for the diagnosis, monitoring, and ultimately screening, of multiple cancers. Glycometrix has conducted clinical trails in ovarian, breast, and prostate cancer and has discovered markers that are both cancer type and stage specific.
Implicit Interfaces	A very low percentrage of apparel sales are conducted online resulting in a loss of tens of billions of dollars each year for the apparel industry. To solve this problem, Implicit Interfaces has created a revolutionary new search technology that leverages computer vision and machine learning techniques. Using this technology, online retailers will increase conversion rates, increase browsing times, and create a remarkably better consumer experience.
Kebima	Kebima is an experience-sharing platform that leverages the ubiquitous access of mobile devices, harnesses the collective perspectives of users, and establishes an event-based online community. Our mission is to create a crowdsourced open-content platformwhere individuals can contribute, read, and consolidate the latest snippets related to an event while interacting with each other live. Our product empowers "social reporters" to report live and publish origianl media to "social viewers" and enables "social organizer"s to consolidate and generate an article for additional event coverage.
LReady	LReady uses web and telephony technology to give families a way to get prepared in less than five minutes for a natural disaster. LReady also offers a free disaster planning tool that helps families build an online emergency plan that monitors their status and generates a recommended list of readiness supplies that can be purchased through the company's ecommerce site. LReady was purchased in 2007 and is currently based in the UC Berkeley Entrepreneurship Laboratory.
Omniox	Omniox is a biotechnology company commercializing a breakthough protein platform technology into first-class and best-in-class oxygen delivery vehicles to treat large unmet needs. Immediate applications for the technolgoy include Radiation Therapy sensitizers for difficult to treat solid tumors and a universal Resuscitation Fluid for trauma and field use. Success of the Omniox platform has the potential to transform healthcare on a global basis.
Reporterist	Reporterist helps journalists monetize high quality, original news content. To date, there is no eBay for news that connects editors with original, well reported content, and makes the transaction itself more efficient. Reporterist built such a content marketplace and will build a publishing platform that helps niche entrepreneurial publishers create professional online magazines.
Titan Medical	Titan Medical is developing novel NanoFlow technology which enables the high-precision and low-cost delivery of a wide variety of therapeutic molecules. NanoFlow technology significantly improves the debilitating side effects and considerable compliance issues that plague many of today's injection therapies.

For more information on the competition please visit the UC Berkeley Business Plan Competition website.

[top of page]